<html>
<head>PUBMED IDs for TRIM44</head>
<body bgcolor='#C5F0F2'><h1>TRIM44</h1><a href='https://pubmed.ncbi.nlm.nih.gov/18314910/'>High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx.</a> March 5  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/22862969/'>Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma.</a> March 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22862967/'>The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis.</a> June 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24777112/'>Amplification of TRIM44: pairing a prognostic target with potential therapeutic strategy.</a> July 9  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26394807/'>Variants in TRIM44 Cause Aniridia by Impairing PAX6 Expression.</a> August 20  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26394757/'>Serum miR-124 up-regulation as a disease marker of toxic epidermal necrolysis.</a> October 13  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27619678/'>High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.</a> September 14  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27754579/'>A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor.</a> October 19  2016<br></body></html>
